SCHEMBL8077611

SCHEMBL8077611

C=CCCCCCCCCCN1C(=O)CCCC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
KMT2A Q03164 1/20 0.47
MGLL Q99685 3/20 0.46
FAAH O00519 2/20 0.46
HTR7 P34969 1/20 0.35
TSHR P16473 1/20 0.34
MAPT P10636 2/20 0.34
ABCC4 O15439 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
ALDH1A1 P00352 2/20 0.33
HSP90AA1 P07900 1/20 0.33
TLR9 Q9NR96 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8432819 1.00 MEN1 (0.47) MEN1POLBKMT2AMGLLFAAH
SCHEMBL8431076 0.98 MEN1 (0.49) MEN1POLBKMT2AMGLLFAAH
SCHEMBL8432105 0.92 MGLL (0.53) MEN1POLBKMT2AMGLLFAAH
SCHEMBL3042779 0.84 FAAH (0.47) MEN1POLBKMT2AMGLLFAAH
SCHEMBL11324053 0.83 FAAH (0.38) MEN1POLBKMT2AMGLLFAAH
SCHEMBL8015571 0.78 MGLL (0.41) MEN1POLBKMT2AMGLLFAAH
SCHEMBL8431018 0.77 MGLL (0.62) MEN1POLBKMT2AMGLLFAAH
SCHEMBL8076187 0.77 L3MBTL1 (0.38) MEN1KMT2ASMN1; SMN2PKMRAB9A
SCHEMBL7867022 0.77 HTR1A (0.50) HTR7ALDH1A1
SCHEMBL11323543 0.76 ADRA1B (0.43) MEN1POLBKMT2ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5521315-A Olefin substituted long chain compounds CELL THERAPEUTICS, INC. (US) 1996-05-28 US claimed
EP-0697873-A4 1996-04-03 EP claimed
EP-0697873-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1996-02-28 EP claimed
WO-1994015606-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-07-21 WO claimed
US-6121270-A N-(EPOXYALKYL)XANTHINE DERIVATIVES WHICH MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI CELL THERAPEUTICS, INC. (US) 2000-09-19 US disclosed
US-5866576-A COMPOUNDS THAT ACT AS DRUGS ON THE CELLULAR AND BIOCHEMICAL LEVEL TO MODULATE CELLULAR RESPONSES TO NOXIOUS, PRO-INFLAMMATORY STIMULI. CELL THERAPEUTICS, INC. (US) 1999-02-02 US disclosed
US-5859017-A PREVENTING OR TREATING ALLERGIES; INHIBITING INTRACELLULAR GENERATION OF PHOSPHATIDIC ACID AND DIACYLGLYCEROL CELL THERAPEUTICS, INC. (US) 1999-01-12 US disclosed
EP-0662834-A4 NOVEL EPOXIDE-CONTAINING COMPOUNDS. CELL THERAPEUTICS INC (US) 1996-04-17 EP disclosed
EP-0697873-A4 1996-04-03 EP disclosed
EP-0697873-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1996-02-28 EP disclosed
EP-0662834-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1995-07-19 EP disclosed
WO-1994015606-A1 OLEFIN-SUBSTITUTED LONG CHAIN COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-07-21 WO disclosed
WO-1994006431-A1 NOVEL EPOXIDE-CONTAINING COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-03-31 WO disclosed